These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 16292330)
21. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis. Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282 [TBL] [Abstract][Full Text] [Related]
22. Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease. Hunt A; Schönknecht P; Henze M; Seidl U; Haberkorn U; Schröder J Psychiatry Res; 2007 Jul; 155(2):147-54. PubMed ID: 17524628 [TBL] [Abstract][Full Text] [Related]
23. Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment. Hampel H; Teipel SJ; Fuchsberger T; Andreasen N; Wiltfang J; Otto M; Shen Y; Dodel R; Du Y; Farlow M; Möller HJ; Blennow K; Buerger K Mol Psychiatry; 2004 Jul; 9(7):705-10. PubMed ID: 14699432 [TBL] [Abstract][Full Text] [Related]
24. Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment. Habert MO; Horn JF; Sarazin M; Lotterie JA; Puel M; Onen F; Zanca M; Portet F; Touchon J; Verny M; Mahieux F; Giron A; Fertil B; Dubois B Neurobiol Aging; 2011 Jan; 32(1):15-23. PubMed ID: 19250707 [TBL] [Abstract][Full Text] [Related]
26. Correlation between neuropsychological tests and hypoperfusion in MCI patients: anatomical labeling using xjView and Talairach Daemon software. Yoon HJ; Park KW; Jeong YJ; Kang DY Ann Nucl Med; 2012 Oct; 26(8):656-64. PubMed ID: 22777857 [TBL] [Abstract][Full Text] [Related]
27. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment]. Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368 [TBL] [Abstract][Full Text] [Related]
28. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT. Hirao K; Ohnishi T; Hirata Y; Yamashita F; Mori T; Moriguchi Y; Matsuda H; Nemoto K; Imabayashi E; Yamada M; Iwamoto T; Arima K; Asada T Neuroimage; 2005 Dec; 28(4):1014-21. PubMed ID: 16129627 [TBL] [Abstract][Full Text] [Related]
29. Effects of a 6-month cognitive intervention on brain metabolism in patients with amnestic MCI and mild Alzheimer's disease. Förster S; Buschert VC; Teipel SJ; Friese U; Buchholz HG; Drzezga A; Hampel H; Bartenstein P; Buerger K J Alzheimers Dis; 2011; 26 Suppl 3():337-48. PubMed ID: 21971473 [TBL] [Abstract][Full Text] [Related]
30. Altered spontaneous activity in Alzheimer's disease and mild cognitive impairment revealed by Regional Homogeneity. Zhang Z; Liu Y; Jiang T; Zhou B; An N; Dai H; Wang P; Niu Y; Wang L; Zhang X Neuroimage; 2012 Jan; 59(2):1429-40. PubMed ID: 21907292 [TBL] [Abstract][Full Text] [Related]
31. Decreased cortical glucose metabolism in converters from CDR 0.5 to Alzheimer's disease in a community: the Osaki-Tajiri Project. Ishii H; Ishikawa H; Meguro K; Tashiro M; Yamaguchi S Int Psychogeriatr; 2009 Feb; 21(1):148-56. PubMed ID: 19040787 [TBL] [Abstract][Full Text] [Related]
34. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. Chételat G; Landeau B; Eustache F; Mézenge F; Viader F; de la Sayette V; Desgranges B; Baron JC Neuroimage; 2005 Oct; 27(4):934-46. PubMed ID: 15979341 [TBL] [Abstract][Full Text] [Related]
35. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Convit A; de Asis J; de Leon MJ; Tarshish CY; De Santi S; Rusinek H Neurobiol Aging; 2000; 21(1):19-26. PubMed ID: 10794844 [TBL] [Abstract][Full Text] [Related]
36. Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease. Park KW; Yoon HJ; Kang DY; Kim BC; Kim S; Kim JW Psychiatry Res; 2012; 203(2-3):201-6. PubMed ID: 22980226 [TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects. Smith GE; Bohac DL; Waring SC; Kokmen E; Tangalos EG; Ivnik RJ; Petersen RC Neurology; 1998 Feb; 50(2):355-62. PubMed ID: 9484353 [TBL] [Abstract][Full Text] [Related]